However, the lower level of sensitivity (71.88%) displayed by the serum IL-23A measurement implies that IL-23A failed to exhibit good diagnostic performance and urges further studies with a larger population size to evaluate the exact role of IL-23A in GAD pathophysiology. This evidence concerns the gene IL23A and generalized anxiety disorder.